Company Listing
Clovis Oncology

Clovis acquires, develops and commercialises innovative anti-cancer drugs in the US, Europe and other international markets. The management team is comprised of the former executives of Pharmion, an earlier Abingworth portfolio company, which was acquired by Celgene for $2.9 billion in 2008. Clovis went public in November 2011.

BACK
Location
Boulder, Colorado
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Clovis acquires, develops and commercialises innovative anti-cancer drugs in the US, Europe and other international markets. The management team is comprised of the former executives of Pharmion, an earlier Abingworth portfolio company, which was acquired by Celgene for $2.9 billion in 2008. Clovis went public in November 2011.

Location
Boulder, Colorado
Website Address
BACK
 
Copyright Abingworth 2017